136 related articles for article (PubMed ID: 1308940)
1. HTLV-II and a new endemic area for HTLV-I in Brazil.
Moreira Júnior ED; Harrington Júnior W; Ribeiro TT; Melo A; Brites C; Badaró R; Swanson P; Lee H
Rev Soc Bras Med Trop; 1992; 25(2):141-3. PubMed ID: 1308940
[No Abstract] [Full Text] [Related]
2. HTLV-I/II seroprevalence in 55 Brazilian patients with idiopathic uveitis.
Pinheiro SR; Carneiro-Proietti AB; Lima-Martins MV; Proietti FA; Pereira AA; Oréfice F
Rev Soc Bras Med Trop; 1996; 29(4):383-4. PubMed ID: 8768591
[No Abstract] [Full Text] [Related]
3. HTLV-I/II seroprevalence in The Gambia: a study of mother-child pairs.
Del Mistro A; Chotard J; Hall AJ; Fortuin M; Whittle H; De Rossi A; Chieco-Bianchi L
AIDS Res Hum Retroviruses; 1994 May; 10(5):617-20. PubMed ID: 7917523
[No Abstract] [Full Text] [Related]
4. A seroepidemiological survey of HTLV-I/HTLV-II in selected Belgian populations.
Vranckx R; Coenjaert A; Muylle L
AIDS Res Hum Retroviruses; 1990 Jul; 6(7):827-30. PubMed ID: 2390333
[TBL] [Abstract][Full Text] [Related]
5. HTLV-I/II antibodies among three different Indian groups from Paraguay.
de Cabral MB; Vera ME; Samudio M; Arias AR; Cabello A; Moreno R; Zapiola I; Bouzas MB; Muchinik G
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):548-9. PubMed ID: 9859972
[No Abstract] [Full Text] [Related]
6. Absence of HTLV-I infection in patients with malignancy in the Yucatan peninsula.
Góngora-Biachi RA; González-Martínez P; Puerto FI; Bastarrachea-Ortíz J; Yamaguchi K; Nishimura Y; Takatsuki K
Rev Invest Clin; 1993; 45(3):281-2. PubMed ID: 8210771
[No Abstract] [Full Text] [Related]
7. Prevalence of antibodies to HTLV-I/II in blood donors and risk populations in South China.
Cao F; Ji Y; Huang R; Lin S
Vox Sang; 1998; 75(2):154. PubMed ID: 9784671
[No Abstract] [Full Text] [Related]
8. Human T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007-2009.
Carneiro-Proietti AB; Sabino EC; Leão S; Salles NA; Loureiro P; Sarr M; Wright D; Busch M; Proietti FA; Murphy EL;
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1265-72. PubMed ID: 22324906
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of antibodies to HTLV-I/II in high-risk patients and blood donors in Denmark.
Christiansen CB; Wantzin P; Dickmeiss E
Vox Sang; 1995; 68(1):63-4. PubMed ID: 7725675
[No Abstract] [Full Text] [Related]
10. Human T-lymphotropic virus type II seroprevalence among emergency department and clinic patients.
Agranoff D; Varney K; Khayam-Bashi H; Murphy EL
West J Med; 1996 Jun; 164(6):481-5. PubMed ID: 8764621
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil.
Catalan-Soares B; Carneiro-Proietti AB; Proietti FA;
Cad Saude Publica; 2005; 21(3):926-31. PubMed ID: 15868051
[TBL] [Abstract][Full Text] [Related]
12. Low human T cell leukemia virus type II seroprevalence in Africa.
Bonis J; Verdier M; Dumas M; Denis F
J Infect Dis; 1994 Jan; 169(1):225-7. PubMed ID: 8277189
[No Abstract] [Full Text] [Related]
13. Serological patterns and temporal trends of HTLV-1/2 infection in high-risk populations attending Public Health Units in São Paulo, Brazil.
Jacob F; Santos-Fortuna E; Azevedo RS; Caterino-de-Araujo A
J Clin Virol; 2008 Jun; 42(2):149-55. PubMed ID: 18346935
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of human T cell leukemia virus in HIV antibody-negative populations in rural Cameroon.
Machuca A; Wood O; Lee S; Daniel S; Rios M; Wolfe ND; Carr JK; Eitel MN; Tamoufe U; Torimiro JN; Burke D; Hewlett IK
Clin Infect Dis; 2005 Jun; 40(11):1673-6. PubMed ID: 15889367
[TBL] [Abstract][Full Text] [Related]
15. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia.
Fawaz NA; Tamim H; Almawi WY
Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of HTLV-I/II in blood donors in Monterrey, Mexico.
Trejo-Avila LM; Fuentes-Pensamiento R; Scorro Flores-Castañeda M; Diaz-Mendoza ML; Zapata-Benavides P; Tamez-Guerra RS
Arch Med Res; 1996; 27(1):97-9. PubMed ID: 8867376
[TBL] [Abstract][Full Text] [Related]
17. Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain.
Treviño A; Aguilera A; Caballero E; Benito R; Parra P; Eiros JM; Hernandez A; Calderón E; Rodríguez M; Torres A; García J; Ramos JM; Roc L; Marcaida G; Rodríguez C; Trigo M; Gomez C; de Lejarazu RO; de Mendoza C; Soriano V;
Virol J; 2012 Mar; 9():71. PubMed ID: 22444832
[TBL] [Abstract][Full Text] [Related]
18. [HTLV-I/II infection in the state of Bahia].
Britto AP; Galvão-Castro B; Straatmann A; Santos-Torres S; Tavares-Neto J
Rev Soc Bras Med Trop; 1998; 31(1):35-41. PubMed ID: 9477696
[TBL] [Abstract][Full Text] [Related]
19. HTLV infection in a group of prostitutes and their male sexual clients in Brazil: seroprevalence and risk factors.
Bellei NC; Granato CF; Tomyiama H; Castelo A; Ferreira O
Trans R Soc Trop Med Hyg; 1996; 90(2):122-5. PubMed ID: 8761567
[TBL] [Abstract][Full Text] [Related]
20. HTLV-I/II indeterminate serology and natural killer cell expansion.
Picchio GR; Bare P; Savignano R; Perez-Bianco R; Yamashita M; Hayami M
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(4):428-31. PubMed ID: 8673555
[No Abstract] [Full Text] [Related]
[Next] [New Search]
